Adhesion molecules play an important role in organogenesis, wound heal
ing, inflammation, and progression of malignant tumors. Three major cl
asses of adhesion molecules may be discriminated by function: (a) calc
ium-dependent homotypic adhesion molecules (e.g. cadherins), (b) subst
rate adhesion molecules (e.g. integrins) and (c) heterotypic adhesion
molecules (e.g. ICAM-1). Molecules of each of the three classes have b
een identified in urologic tumors. Results of research on substrate ad
hesion molecules and heterotypic adhesion molecules have not yet led t
o new clinical concepts. In contrast, loss of E-cadherin in tumors of
the bladder and prostate has been clearly associated with de-different
iation of tumors and diminished survival of patients. Loss of another
adhesion molecule, C-CAM, has been observed in prostate cancer. This h
as led to new therapeutic approaches, which are in an experimental sta
ge at present. It may be expected that, in the future, new therapeutic
concepts will be based on research on adhesion molecules in urologic
tumors.